Why PTC Therapeutics, Inc. Is Crashing Today

Image source Getty Images What happened After providing investors with two regulatory updates related to its nonsense mutation Duchenne muscular dystrophy nmDMD drug Translarna shares of PTC Therapeutics NASDAQ PTCT fell by 31 as of 12 00 p m EDT on Monday So